Equities

Epigral Ltd

EPIGRAL:NSI

Epigral Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)1,288.00
  • Today's Change13.75 / 1.08%
  • Shares traded10.84k
  • 1 Year change+37.02%
  • Beta--
Data delayed at least 15 minutes, as of May 18 2024 07:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Epigral Limited, formerly Meghmani Finechem Limited, is an India-based manufacturer of essential chemicals. The Company is engaged in manufacturing and selling chlor alkali and its derivatives. It is also engaged in the trading of agrochemical products. The Company manufactures a range of products, such as chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.

  • Revenue in INR (TTM)19.29bn
  • Net income in INR1.96bn
  • Incorporated2007
  • Employees936.00
  • Location
    Epigral LtdShree Nivas Society, Paldi, GujaratAHMEDABAD 380015IndiaIND
  • Phone+91 7 929709600
  • Fax+91 7 929709605
  • Websitehttps://epigral.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Rossari Biotech Ltd18.31bn1.31bn38.63bn500.0029.603.6920.222.1123.6223.62330.69189.651.255.494.70--8.8910.5312.0614.3429.3429.847.147.661.329.860.10182.2610.5528.8121.8523.3924.44--
Fineotex Chemical Ltd5.54bn1.16bn39.89bn103.0034.51--32.737.2110.4410.4450.02--------53,751,720.00--17.65--21.9038.3335.2121.0515.49--136.92--8.2540.4029.3260.0731.2346.9631.95
Bharat Rasayan Ltd10.41bn586.50m40.52bn797.0069.09--47.923.89141.16141.162,505.13--------13,060,150.00--17.10--22.8828.4728.495.6312.57--28.84--0.4305-5.138.78-29.194.85-10.500.00
Nocil Ltd14.81bn1.20bn43.59bn675.0036.51--25.182.947.167.1688.59--------21,939,110.00--9.20--10.4343.1436.298.0912.15--99.39--38.642.8810.32-15.31-2.57-8.973.71
Privi Speciality Chemicals Ltd17.52bn949.07m44.58bn725.0046.724.8220.372.5424.4324.43447.68236.640.74031.575.45--4.035.097.038.5334.5030.725.456.480.53842.060.51726.148.985.49327.230.1404-2.31-4.36
AMI Organics Ltd7.17bn427.73m46.12bn602.0095.396.8471.536.4313.1113.11199.16182.750.77032.983.29--5.2310.476.9314.4742.6245.446.7911.761.1918.930.240911.7816.3325.14-48.6512.9267.37--
GHCL Ltd34.43bn7.94bn47.92bn3.84k6.011.615.351.3983.2683.26361.06311.150.77352.7817.29--17.8314.1819.6617.1842.6139.4323.0618.662.7328.150.065914.59-24.180.622-28.8517.76-17.7419.14
National Fertilizers Limited245.60bn-2.94bn49.92bn2.99k----76.440.2033-5.99-5.99501.09--------82,139,260.00--1.25--2.869.4816.40-1.200.884---2.37----86.7727.03582.4016.59-9.37--
Sudarshan Chemical Industries Ltd24.66bn3.32bn50.91bn1.03k15.44--10.882.0647.6347.63350.86--------24,032,330.00--6.44--11.5444.0233.5613.466.14--2.88--25.424.5911.23-65.55-10.2617.13-15.59
Epigral Ltd19.29bn1.96bn52.95bn936.0027.044.2216.572.7447.1347.13464.18301.830.73824.9111.18--7.50--10.31--39.53--10.15--0.30654.870.4346---11.84---44.57------
Rallis India Ltd26.48bn1.48bn53.98bn1.72k36.192.9520.602.047.677.67136.6194.050.9131.974.91--5.106.157.809.7040.4532.575.596.330.954810.940.067832.11-10.755.9460.97-0.969112.000.00
Paradeep Phosphates Ltd115.75bn999.10m56.42bn1.48k56.301.5818.170.48751.231.23141.6543.751.144.423.61--0.98353.422.308.6622.2620.390.86312.890.75131.200.5297---13.2321.58-67.16-8.8726.66--
Gujarat Alkalies And Chemicals Ltd39.43bn-1.20bn59.42bn1.34k----23.901.51-16.28-16.28536.88--------29,448,320.00--6.50--7.1528.4241.83-3.0313.00---0.1149--14.2420.1612.43-26.82-5.1819.1229.36
Dhanuka Agritech Ltd17.59bn2.39bn60.34bn1.04k25.244.8021.583.4352.4652.46385.85275.541.182.815.13--16.0217.3019.8622.0839.0336.6613.6013.922.1992.940.021--3.4311.822.3916.2671.20--
Indigo Paints Ltd12.47bn1.42bn65.40bn848.0046.02--34.835.2529.8429.84261.35--------14,701,380.00--11.28--16.8147.0444.8211.489.36--88.00--8.5518.4721.7356.9859.3058.79--
Data as of May 18 2024. Currency figures normalised to Epigral Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

0.85%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 09 May 2024182.58k0.44%
BlackRock Advisors (UK) Ltd.as of 09 May 202443.14k0.10%
BlackRock Fund Advisorsas of 09 May 202432.82k0.08%
American Century Investment Management, Inc.as of 09 May 202424.12k0.06%
SSgA Funds Management, Inc.as of 09 May 202423.57k0.06%
Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 202420.00k0.05%
TIAA-CREF Investment Management LLCas of 31 Mar 202412.42k0.03%
Dimensional Fund Advisors Ltd.as of 29 Feb 20248.24k0.02%
State Street Global Advisors Ltd.as of 09 May 20243.73k0.01%
DFA Australia Ltd.as of 31 Mar 20241.57k0.00%
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.